Bruce C Cozadd - Net Worth and Insider Trading

Bruce C Cozadd Net Worth

The estimated net worth of Bruce C Cozadd is at least $53 Million dollars as of 2024-11-28. Bruce C Cozadd is the Chairman & CEO of Jazz Pharmaceuticals PLC and owns about 428,976 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $53 Million. Details can be seen in Bruce C Cozadd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bruce C Cozadd has not made any transactions after 2024-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bruce C Cozadd

To

Bruce C Cozadd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bruce C Cozadd owns 4 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) , Cerus Corp (CERS) , and Molecular Templates Inc (MTEM) among others .

Click here to see the complete history of Bruce C Cozadd’s form 4 insider trades.

Insider Ownership Summary of Bruce C Cozadd

Ticker Comapny Transaction Date Type of Owner
JAZZ Jazz Pharmaceuticals PLC 2024-11-01 director & Executive Chairman
CERS Cerus Corp 2003-09-01 director
MTEM Molecular Templates Inc 2016-06-24 director
LIMIT LIMIT 2023-05-04 director

Bruce C Cozadd Latest Holdings Summary

Bruce C Cozadd currently owns a total of 1 stock. Bruce C Cozadd owns 428,976 shares of Jazz Pharmaceuticals PLC (JAZZ) as of November 1, 2024, with a value of $53 Million.

Latest Holdings of Bruce C Cozadd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JAZZ Jazz Pharmaceuticals PLC 2024-11-01 428,976 122.64 52,609,617

Holding Weightings of Bruce C Cozadd


Bruce C Cozadd Form 4 Trading Tracker

According to the SEC Form 4 filings, Bruce C Cozadd has made a total of 31 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 31 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,000 shares on November 1, 2024, which brought Bruce C Cozadd around $110,840.

Insider Trading History of Bruce C Cozadd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bruce C Cozadd Trading Performance

GuruFocus tracks the stock performance after each of Bruce C Cozadd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce C Cozadd is 96.41%. GuruFocus also compares Bruce C Cozadd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce C Cozadd within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bruce C Cozadd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bruce C Cozadd

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 22.53 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.29 LIMIT LIMIT LIMIT LIMIT LIMIT

Bruce C Cozadd Ownership Network

Ownership Network List of Bruce C Cozadd

No Data

Ownership Network Relation of Bruce C Cozadd

Insider Network Chart

Bruce C Cozadd Owned Company Details

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

Bruce C Cozadd is the director & Executive Chairman of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include SVP & General Counsel Neena M Patil , SVP & Technical Operations Mary Elizabeth Henderson , and VP & Finance& PAO Patricia Carr .

Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary

Over the past 18 months, Bruce C Cozadd made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 12,550 shares made by Neena M Patil , a net sale of 4,293 shares made by Patricia Carr , and a net sale of 1,658 shares made by Mark Douglas Smith .

In summary, during the past 3 months, insiders sold 6,110 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 6,110 shares. During the past 18 months, 32,600 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 20,600 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

Bruce C Cozadd Mailing Address

Above is the net worth, insider trading, and ownership report for Bruce C Cozadd. You might contact Bruce C Cozadd via mailing address: C/o Jazz Pharmaceuticals Plc, 5th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4 L2 00000.

Discussions on Bruce C Cozadd

No discussions yet.